Combinostics at RSNA 2023
RSNA 2023
Attending RSNA 2022? Stop by booth 3938 in the AI Showcase to learn about our complete solution for early detection, diagnosis, and management of neurological disorders.
Combinostics new PET quantification application cNeuro cPET receives FDA 510(k) clearance
New cPET application for amyloid and FDG brain PET quantification further extends Combinostics’ solutions across the entire patient pathway for neurological disorders and supports end-to-to-end workflows.
Combinostics New PET Quantification application cNeuro cPET released in Europe
New cPET application for amyloid and FDG brain PET quantification further extends Combinostics’ solutions across the entire patient pathway for neurological disorders and supports end-to-to-end workflows
AAIC 2023
Attending ASNR 2023? Stop by booth 603 to learn about our complete solution for the early detection, diagnosis, and management of neurological disorders.
SNMMI 2023
Attending ASNR 2023? Stop by booth 603 to learn about our complete solution for the early detection, diagnosis, and management of neurological disorders.
Revolutionising Precision Medicine: PROMINENT Project will Enhance Diagnosis and Treatment of Neurodegenerative Diseases, Improving Patients’ Lives Across Europe
Stockholm, 14 June 2023 – Today, partners of the PROMINENT project announced the launch of…
